Influenza H7N9 Hemagglutinin / HA ELISA Kit

Similar documents
Human BMP-2 ELISA Kit

Human C-Reactive Protein/CRP ELISA Kit

Influenza A H1N1 (A/Puerto Rico/8/1934) Hemagglutinin / HA ELISA Kit

Mouse IL-18 ELISA Kit

Human CEACAM6 / CD66c ELISA Kit

Human Immunodeficiency Virus type 1 (HIV-1) gp120 / Glycoprotein 120 ELISA Kit

Human TNF-alpha ELISA Kit

Human IL6 / IL-6 ELISA Kit

小鼠 PCSK9 ELISA检测试剂盒

Make High-Quality Affordable

Human Immunodeficiency Virus type 1 (HIV-1) p24 / Capsid Protein p24 ELISA Kit

Influenza H3N2 Hemagglutinin / HA ELISA Kit

Human Immunodeficiency Virus type 1 (HIV-1) p24 / Capsid Protein p24 ELISA Kit

Human DLL4 / Delta-like 4 ELISA Kit

Human Complement Component C2 ELISA Kit

Influenza H1N1 Hemagglutinin / HA ELISA Kit

Human Angiotensinogen / SerpinA8 / AGT ELISA Kit

Microsoft Word - HC20138_2010.doc

ch_code_infoaccess

Chn 116 Neh.d.01.nis

1505.indd

Preface This guide is intended to standardize the use of the WeChat brand and ensure the brand's integrity and consistency. The guide applies to all d

OA-253_H1~H4_OL.ai

Nebulizer Treatments - Simplified Chinese

PowerPoint Presentation

BC04 Module_antenna__ doc

Microsoft Word - ChineseSATII .doc

2015 Chinese FL Written examination

<453A5CCAB3C6B7BFC6D1A73131C4EA3134C6DA5C3134C6DA5C3032B7D6CEF6>

4. 每 组 学 生 将 写 有 习 语 和 含 义 的 两 组 卡 片 分 别 洗 牌, 将 顺 序 打 乱, 然 后 将 两 组 卡 片 反 面 朝 上 置 于 课 桌 上 5. 学 生 依 次 从 两 组 卡 片 中 各 抽 取 一 张, 展 示 给 小 组 成 员, 并 大 声 朗 读 卡

Pneumonia - Traditional Chinese

Microsoft Word - 第四組心得.doc

小 鼠 胰 岛 素 原 (PI) 化 学 发 光 免 疫 分 析 试 剂 盒 使 用 说 明 书 产 品 编 号 :E-CL-M0572c ( 本 试 剂 盒 仅 供 体 外 研 究 使 用 不 用 于 临 床 诊 断!) 声 明 : 尊 敬 的 客 户, 感 谢 您 选 用 本 公 司 的 产 品

LH_Series_Rev2014.pdf

國家圖書館典藏電子全文

東吳大學

Binder1.pdf

Microsoft Word doc

CSB-E07967r

猪 神 经 营 养 因 子 3(NT-3) 酶 联 免 疫 吸 附 测 定 试 剂 盒 使 用 说 明 书 产 品 货 号 :E-EL-P0212c ( 本 试 剂 盒 仅 供 体 外 研 究 使 用 不 用 于 临 床 诊 断!) 声 明 : 尊 敬 的 客 户, 感 谢 您 选 用 本 公 司

ELISA分析

SDS 1.3

Microsoft PowerPoint _代工實例-1

HC20131_2010

入學考試網上報名指南

國 史 館 館 刊 第 23 期 Chiang Ching-kuo s Educational Innovation in Southern Jiangxi and Its Effects ( ) Abstract Wen-yuan Chu * Chiang Ching-kuo wa

42

g ml 10% ph 色谱条件 kinetex C μm 100 A 4. 6 mm 150 mm 25 5 μl A B 10 mmol /L ml /min

Microsoft PowerPoint - ATF2015.ppt [相容模式]

CSB-E09815h

東莞工商總會劉百樂中學

2012 年 4 月 至 6 月 活 動 一 覽 月 份 計 劃 / 項 目 活 動 4 月 竹 園 中 心 活 動 竹 園 中 心 開 放 日 暨 沒 有 巴 掌 日 嘉 年 華 :4 月 28 日 v 迎 新 會 :4 月 21 日 童 歡 部 落 v 義 工 服 務 :5 月 27 日 v 小

CSB-E06869r

HCD0174_2008

%

States and capital package

GB Sparkle

鼠 疫(Plague)

Microsoft Word - template.doc

Male Circumcision - Traditional Chinese

Male Circumcision - Simplified Chinese

Settlement Equation " H = CrH 1+ e o log p' o + ( p' p' c o! p' o ) CcH + 1+ e o log p' c + p' f! ( p' p' c c! p' o ) where ΔH = consolidation settlem

第一章 緒論

穨control.PDF

HC50246_2009

OVLFx3C7_Series_A3_bgry-KB.pub

OncidiumGower Ramsey ) 2 1(CK1) 2(CK2) 1(T1) 2(T2) ( ) CK1 43 (A 44.2 ) CK2 66 (A 48.5 ) T1 40 (

上海酶研生物科技有限公司

受訪者編號:

Microsoft Word - (web)_F.1_Notes_&_Application_Form(Chi)(non-SPCCPS)_16-17.doc

2017 CCAFL Chinese in Context

Microsoft Word - 中級會計學--試題.doc

從詩歌的鑒賞談生命價值的建構

168 健 等 木醋对几种小浆果扦插繁殖的影响 第1期 the view of the comprehensive rooting quality, spraying wood vinegar can change rooting situation, and the optimal concent

CSB-E05071m

1.ai

Microsoft Word - Final Exam Review Packet.docx


Bottle Feeding Your Baby - Simplified Chinese

國 立 政 治 大 學 教 育 學 系 2016 新 生 入 學 手 冊 目 錄 表 11 國 立 政 治 大 學 教 育 學 系 博 士 班 資 格 考 試 抵 免 申 請 表 論 文 題 目 申 報 暨 指 導 教 授 表 12 國 立 政 治 大 學 碩 博 士 班 論

< F63756D656E D2D796E2D31C6DABFAF2D31D6D0D2BDD2A9CFD6B4FABBAF2D C4EA2DB5DA35C6DA2D30322DD7A8C0FBD0C5CFA2D7CAD4B4D1D0BEBF35C6DA2E6D6469>

Microsoft Word - Lenovo_L15M3PB2 (Winbook)_3S1P_UN38.3 Test Report_SLEU

Microsoft Word - 大陸化粧品進口程序與法規1220(16K)

89???????q?l?????T??

Table of Contents Introduction Description 1 Principle of the Assay 1 Limitations of the Procedure 1 General Information Materials Provided 3 Other Su

Important Notice SUNPLUS TECHNOLOGY CO. reserves the right to change this documentation without prior notice. Information provided by SUNPLUS TECHNOLO

卡尔费休库仑滴定仪和水蒸发器测量卡氏炉标准物质

Microsoft Word - TIP006SCH Uni-edit Writing Tip - Presentperfecttenseandpasttenseinyourintroduction readytopublish

Table of Contents Introduction Description 1 Principle of the Assay 1 Limitations of the Procedure 1 General Information Materials Provided 3 Other Su

Microsoft PowerPoint - AWOL - Acrobat Windows Outlook.ppt [Compatibility Mode]

國立中山大學學位論文典藏.PDF

1. 請 先 檢 查 包 裝 內 容 物 AC750 多 模 式 無 線 分 享 器 安 裝 指 南 安 裝 指 南 CD 光 碟 BR-6208AC 電 源 供 應 器 網 路 線 2. 將 設 備 接 上 電 源, 即 可 使 用 智 慧 型 無 線 裝 置 進 行 設 定 A. 接 上 電 源

Applied Biosystems StepOne™ Real-Time PCR System Quick Reference Card for Installation

Rat Insulin-like Growth Factor I ELISA kit

mm 5 1 Tab 1 Chemical composition of PSB830 finishing rolled rebars % C Si Mn P S V 0 38 ~ 1 50 ~ 0 80 ~ ~

Transcription:

Influenza H7N9 Hemagglutinin / HA ELISA Kit Catalog Number: KIT40104 Please read this instruction manual carefully before using the product. For Research Use Only. Not for use in diagnostic or therapeutic procedures. Fax :+86-10-58628220 Tel:+86-400-890-9989 http://www.sinobiological.com

Make High-Quality Affordable

BACKGROUND...1 INTENDED USE...2 PRINCIPLE OF THE ASSAY...3 MATERIALS PROVIDED...4 STORAGE...5 OTHER SUPPLIES REQUIRED...7 PRECAUTIONS...8 SAFETY INSTRUCTIONS...8 TECHINICAL TIPS...8 TYPICAL DATA...13 PRECISION...14 RECOVERY...14 LINEARITY...14 SENSITIVITY...15 CALIBRATION...15 SPECIFICITY...16 TROUBLE SHOOTING...17 PRECAUTIONS_ 中文版...19 SAFETY INSTRUCTIONS_ 中文版...19 TECHINICAL TIPS_ 中文版...19 REAGENT PREPARATION_ 中文版...20 CALCULATION OF RESULTS_ 中文版...22 TYPICAL DATA_ 中文版...23 ASSAY SUMMARY...25 ASSAY SUMMARY_ 中文版...26

BACKGROUND On April 1, 2013, the World Health Organization (WHO) first reported 3 human infections with a new influenza A (H7N9) virus in China. Since then, additional cases have been reported. Most reported cases have severe respiratory illness and, in some cases, have died. At this time, no cases of H7N9 outside of China have been reported. The new H7N9 virus has not been detected in people or birds in the United States. This new H7N9 virus is an avian (bird) influenza (flu) virus. Human infections with avian influenza (AI, or "bird flu") are rare but have occurred in the past, most commonly after exposure to infected poultry. However, this is the first time that this bird flu subtype (H7N9) has been found in people. This virus is very different from other H7N9 viruses previously found in birds. H7N9 viruses have been detected in poultry in the same area where human infections have occurred. Many of the human cases of H7N9 are reported to have had contact with poultry. However some cases reportedly have not had such contact. Close contacts of confirmed H7N9 patients are being followed to see if any human-to-human spread of H7N9 might have occurred. Based on previous experience with other avian influenza viruses most notably H5N1 some limited human-to-human spread of this H7N9 virus would not be surprising. Most importantly, however, no sustained person-to-person spread of the H7N9 virus has been found at this time. Ongoing (sustained) person-to-person spread is necessary for a pandemic to occur. The influenza viral Hemagglutinin (HA) protein is a homo trimer with a receptor binding pocket on the globular head of each monomer, and the influenza viral neuraminidase (NA) protein is a tetramer with an enzyme active site on the head of each monomer. Subtypes are further divided into strains; each genetically distinct virus isolate is usually considered to be a separate strain. The influenza virus Hemagglutinin (HA) protein is translated in cells as a single protein, HA0, or hemagglutinin precursor protein. For viral activation, hemagglutinin precursor protein (HA0) must be cleaved by a trypsin-like serine endoprotease at a specific site, normally coded for by a single basic amino acid (usually arginine) between the HA1 and HA2 domains of the protein. After 1

cleavage, the two disulfide-bonded protein domains produce the mature form of the protein subunits as a prerequisite for the conformational change necessary for fusion and hence viral infectivity. INTENDED USE The kit has been verified by high purity Influenza H7N9 Hemagglutinin / HA recombinant protein. The use of this kit for natural samples need be validated by the end user due to the complexity of natural targets and unpredictable interference. 2

PRINCIPLE OF THE ASSAY The principle of this ELISA kit is based on the solid phase sandwich enzyme immunoassay technique. A monoclonal antibody specific for Influenza H7N9 Hemagglutinin / HA has been pre-coated onto well plate strips. Standards and samples are added to the wells and Influenza H7N9 Hemagglutinin / HA present in the sample is bound by the immobilized antibody. After incubation the wells are washed and a horseradish peroxidase conjugated anti-influenza H7N9 Hemagglutinin / HA antibody is added, producing an antibody-antigen-antibody "sandwich complex". Following a wash to remove any unbound antibody a TMB substrate solution is loaded and color develops in proportion to the amount of Influenza H7N9 Hemagglutinin / HA bound. The reaction is stopped by the addition of a stop solution and the intensity of the color can be measured at 450 nm (See schematics below). 3

MATERIALS PROVIDED Influenza H7N9 Hemagglutinin / HA Microplate - 96 well polystyrene microplate (12 strips of 8 wells) coated with rabbit mab antibody against Influenza H7N9 Hemagglutinin / HA. Influenza H7N9 Hemagglutinin / HA Detecion Antibody - 0.2 mg/ml of rabbit pab antibody against Influenza H7N9 Hemagglutinin / HA conjugated to horseradish peroxidase (HRP) with preservatives. Influenza H7N9 Hemagglutinin / HA Standard - Recombinant Influenza H7N9 (A/Shanghai/1/2013) Hemagglutinin / HA in a buffer with preservatives, lyophilized. The amount of standard is lot specific and indicated on the label of standard vial. Wash Buffer Concentrate - 25 ml of a 20-fold concentrated solution of buffered surfactant with preservatives. Dilution Buffer Concentrate - 8 ml of a 20-fold concentrated dilution buffer with preservatives. Color Reagent A - 13 ml of stabilized hydrogen peroxide. Color Reagent B - 13 ml of stabilized chromogen (tetramethylbenzidine). Stop Solution - 8 ml of 2 N sulfuric acid. 4

STORAGE Unopened Kit Store at 2-8 and the kit is stable for 6 months upon receipt. Diluted Wash Buffer Diluted Dilution Buffer Stored for up to 1 week at 2-8 Conjugate Stop Solution Opened/ Reconstituted Reagents Unmixed Color Reagent A Unmixed Color Reagent B Standard Stored for up to 1 month at 2-8 After reconstitution, store for up to 1 month at -80. The reconstituted standards should be aliquoted and avoid repeated freeze-thaw cycles. Microplate Wells Return unused strips to the foil pouch containing the desiccant pack and reseal along entire edge of zip-seal. Stored for up to 1 month at 2-8 5

6

OTHER SUPPLIES REQUIRED Microplate reader capable of measuring absorbance at 450 nm Pipettes and pipette tips Deionized or distilled water Multi -channel pipette, squirt bottle, manifold dispenser, or automated microplate washer 500 ml graduated cylinder Tubes for standard dilution Well plate cover or seals 7

PRECAUTIONS 1. This kit is for research use only and is not for use in diagnostic or therapeutic procedures. 2. The kit should not be used beyond the expiration date. 3. Do not mix reagents from different lots. 4. The kit is designed and tested to detect the specific targets and samples shown in the manual. The use of this kit for other purpose should be verified carefully by the end user. SAFETY INSTRUCTIONS 5. The Stop Solution provided with this kit is an acid solution. Take care when using the reagent to avoid the risk. 6. All biological materials should be handled and discarded as potentially hazardous following local laws and regulations. 7. Personal protective equipments such as lab coats, gloves, surgical masks and goggles are necessary in experiments for safety reasons. TECHINICAL TIPS 8. Bring all reagents and samples to room temperature before use. 9. Samples should be thawed completely and mixed well prior to analysis. Avoid repeated freeze-thaw cycles of frozen samples. 10. A standard curve should be generated for each set of sample assayed. DO NOT USE the standard curves from other plates or other days. 11. Use a new disposable reagent reservoir and new disposable pipette tips for each transfer to avoid cross-contamination. 12. Read the absorbance of each well within 20 minutes after adding the stop solution. 8

REAGENT PREPARATION Bring all reagents to room temperature before use. If crystals have formed in buffer solution, warm to room temperature and mix gently until the crystals have completely dissolved. Wash Buffer - Prepare 1 wash buffer by adding 20 ml of Wash Buffer Concentrate to deionized or distilled water to prepare 400 ml of Wash Buffer. Dilution Buffer - Prepare 1 dilution buffer by adding 5 ml of Dilution Buffer Concentrate to deionized or distilled water to prepare 100 ml of Dilution Buffer. Detection Antibody - Centrifuge at 10,000 x g for 20 seconds. Dilute to work concentration of 0.5 μg/ml in Dilution Buffer before use. Substrate Solution - Color Reagents A and B should be mixed together in equal volumes within 15 minutes of use. Protect from light. 200 μl of the resultant mixture is required per well. Take care not to contaminate the Color Reagent. If the mixed color reagent is blue. DO NOT USE. Influenza H7N9 Hemagglutinin / HA Standard - Reconstitute the Influenza H7N9 (A/Shanghai/1/2013) Hemagglutinin / HA Standard with 1 ml of Dilution Buffer to make stock solution. Shake the vial gently until the lyophilized powder totally dissolved (Do not turn the vial upside down). Mix the standard to ensure complete reconstitution prior to making dilutions. Prepare serially diluted standards as described in the following step: Pipette 1000 μl of Dilution Buffer into the 1000 pg/ml tube. Pipette 500 μl of Dilution Buffer into the remaining tubes. Use the stock solution to produce a dilution series as the following figure. Mix each tube thoroughly before the next transfer. The 1000 pg/ml standard serves as the high standard. The Dilution Buffer serves as the zero standard (0 pg/ml). Ensures each assay has a standard curve. DO NOT USE the standard curve on other plates or other days. The following graph is only for demonstration purposes. The concentration of stock solution is lot specific and need be calculated with the actual amount of standard labeled on the standard vial. 9

10

ASSAY PROCEDURE Bring all reagents and samples to room temperature before use. It is recommended that all samples and standards be assayed in duplicate. 1. Prepare all reagents, working standards, and samples as directed in the previous sections. 2. Remove unused microplate strips from the plate frame, return them to the foil pouchcontaining the desiccant pack, and reseal. 3. Wash each well three times with Wash Buffer (300 μl/well) using a squirt bottle, multi-channel pipette, manifold dispenser or autowasher. Complete removal of liquid at each step is essential to good performance. Remove any remaining Wash Buffer by aspirating or decanting. Invert the plate and blot it against clean paper towels. 4. Add 100 μl of each serially diluted protein standard or test sample per well including a zero standard. Ensure reagent addition is uninterrupted and completed within 15 minutes. Cover/seal the plate and incubate for 2 hours at room temperature. 5. Repeat the aspiration/wash as in Step 3. 6. Add 100 μl of Detection Antibody in working concentration to each well. Cover/seal the plate and incubate for 1 hour at room temperature. 7. Repeat the aspiration/wash as in Step 3. 8. Add 200 μl of Substrate Solution to each well. Incubate for 20 minutes at room temperature. Protect from light. 9. Add 50 μl of Stop Solution to each well. If color change does not appear uniform, gently tap the plate to ensure thorough mixing. 10. Determine the optical density of each well within 20 minutes, using a microplate reader set to 450 nm. 11

CALCULATION OF RESULTS If samples generate values higher than the highest standard, dilute the samples and repeat the assay. Calculate the mean absorbance for each standard, control and sample and subtract average zero standard optical density (O.D.). Construct a standard curve by plotting the mean absorbance for each standard on the y-axis against the concentration on the x-axis and draw a best fit curve through the points on the graph. Most graphing software can help make the curve and a four parameter logistic (4-PL) usually provide the best fit, though other equations (e.g. linear, log/log) can also be tried to see which provides the most accurate. Extrapolate the target protein concentrations for unknown samples from the standard curve plotted. 12

TYPICAL DATA This standard curve is only for demonstration purposes. A standard curve should be generated for each assay. 13

PRECISION Intra-assay Precision (Precision within an assay) Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision. Inter-assay Precision (Precision between assays) Three samples of known concentration were tested in five separate assays to assess inter-assay precision. RECOVERY The recovery of Influenza H7N9 Hemagglutinin / HA spiked to different levels throughout the range of the assay in related matrices was evaluated. LINEARITY 14

SENSITIVITY The minimum detectable dose (MDD) of Influenza H7N9 Hemagglutinin / HA is typically less than 3 pg/ml. The MDD was determined by adding three standard deviations to the mean optical density value of twenty zero standard replicates and calculating the corresponding concentration. CALIBRATION This immunoassay is calibrated against a highly purified recombinant Influenza H7N9 (A/Shanghai/1/2013) Hemagglutinin / HA produced at Sino Biologcial Inc., (Cat# 40104-V08H). 15

SPECIFICITY This assay recognizes most of recombinant H7N9 proteins.influenza A H7N9 (A/Shanghai/2/2013) Hemagglutinin / HA is used as the standard. Crossreaction with other H7N9 strains are as follows: Cat: Observed Cross Expressed Concentration Strain Value reaction Host: (pg/ml) (pg/ml) rates 40103-V08H Human Cells H7N9 (A/Anhui/1/2013) HA Protein 500 611 122% 40103-V08H1 Human Cells H7N9 (A/Anhui/1/2013) HA Protein (HA1 Subunit) 500 232 46% 40103-V08B Insect Cells H7N9 (A/Anhui/1/2013) HA Protein 500 621 124% 40103-V08H4 Human Cells H7N9 (A/Anhui/1/2013) HA Protein (HA1+HA2, cleavage) 500 124 25% 40104-V08H Human Cells H7N9 (A/Shanghai/1/2013) HA Protein 500 720 144% 40104-V08H1 Human Cells H7N9 (A/Shanghai/1/2013) HA Protein (HA1 Subunit) 500 250 50% 40104-V08B Insect Cells H7N9 (A/Shanghai/1/2013) HA Protein 500 722 144% 40104-V08B1 Insect Cells H7N9 (A/Shanghai/1/2013) HA Protein (HA1 Subunit) 500 352 70% 40104-V08H4 Human Cells H7N9 (A/Shanghai/1/2013) HA Protein (HA1+HA2, cleavage) 500 282 56% 40105-V08H Human Cells H7N9 (A/Hangzhou/1/2013) HA Protein 500 10 2% 40105-V08H1 Human Cells H7N9 (A/Hangzhou/1/2013) HA Protein (HA1 Subunit) 500 299 60% 40105-V08B Insect Cells H7N9 (A/Hangzhou/1/2013) HA Protein 500 611 122% 40106-V08H Human Cells H7N9 (A/Pigeon/Shanghai/S1069/2013) HA Protein 500 660 132% 40106-V08H1 Human Cells H7N9 (A/Pigeon/Shanghai/S1069/2013) HA Protein (HA1 Subunit) 500 228 46% 40106-V08B Insect Cells H7N9 (A/Pigeon/Shanghai/S1069/2013) HA Protein 500 883 177% 40106-V08B1 Insect Cells H7N9 (A/Pigeon/Shanghai/S1069/2013) HA Protein (HA1 Subunit) 500 134 27% 40123-V08B Insect Cells H7N9 (A/Hangzhou/3/2013) HA Protein 500 404 81% 40125-V08B Insect Cells H7N9 (A/Zhejiang/1/2013) HA Protein 500 564 113% 40126-V08B Insect Cells H7N9 (A/Shanghai/4664T/2013) HA Protein 500 401 80% 40239-V08H Human Cells H7N9 (A/Shanghai/2/2013) HA Protein 500 445 89% 40239-V08B Insect Cells H7N9 (A/Shanghai/2/2013) HA Protein 500 375 75% 40325-V08H Human Cells H7N9 (A/Zhejiang/DTID-ZJU10/2013) HA Protein 500 192 38% 40325-V08B Insect Cells H7N9 (A/Zhejiang/DTID-ZJU10/2013) HA Protein 500 632 126% 11082-V08H Human Cells H7N7 (A/Netherlands/219/03) HA Protein 1000 140 14% 16

The representative strains that belonged to other subtype listed below were prepared at 50 ng/ml in dilution buffer and assayed for cross-reactivity. No cross-reactivity was observed. Cat Expressed Host: Strain 11053-V08H Human Cells Influenza B virus (B/Florida/4/2006) HA Protein 40016-V08H Human Cells Influenza B (B/Brisbane/60/2008) HA Protein 11052-V08H Human Cells H1N1 (A/Brisbane/59/2007) HA Protein 11684-V08H Human Cells H1N1 (A/Puerto Rico/8/34) HA Protein 11055-V08H Human Cells H1N1 (A/California/04/2009) HA Protein 11688-V08H Human Cells H2N2 (A/Canada/720/2005) HA Protein 11056-V08H Human Cells H3N2 (A/Brisbane/10/2007) HA Protein 11707-V08H Human Cells H3N2 (A/Aichi/2/1968) HA Protein 11706-V08H Human Cells H4N6 (A/Swine/Ontario/01911-1/99) HA Protein 11048-V08B Insect Cells H5N1 (A/Anhui/1/2005) HA Protein 40158-V08B Insect Cells H5N1 (A/chicken/VietNam/NCVD-016/2008) HA Protein 11723-V08H Human Cells H6N1 (A/northern shoveler/california/hkwf115/2007) HA Protein 11722-V08H Human Cells H8N4 (A/pintail duck/alberta/114/1979) HA Protein 11229-V08H Human Cells H9N2 (A/Hong Kong/1073/99) HA Protein 40359-V08B Insect Cells H10N8 (A/Jiangxi-Donghu/346/2013) HA Protein 11705-V08H Human Cells H11N2 (A/duck/Yangzhou/906/2002) HA Protein 11718-V08H Human Cells H12N5 (A/green-winged teal/alb/199/1991) HA Protein 11721-V08H Human Cells H13N8 (A/black-headed gull/netherlands/1/00) HA Protein 11720-V08H Human Cells H15N8 (A/duck/AUS/341/1983) HA Protein 11711-V08H Human Cells H16N3 (A/black-headed gull/sweden/5/99) HA Protein 40324-V08B Insect Cells H18N11 (A/flat-faced bat/peru/033/2010) HA Protein 17

TROUBLE SHOOTING Problems Possible Sources Solutions No signal Poor Standard Curve Poor detection value High Background Incorrect or no Detection Antibody was added Substrate solution was not added Incorrect storage condition Standard was incompletely reconstituted or was inappropriately stored Imprecise / inaccurate pipetting Incubations done at inappropriate temperature, timing or agitation Background wells were contaminated The concentration of antigen in samples was too low Samples were ineffective Insufficient washes Color Reagent should be clear and colorless prior to addition to wells Add appropriate Detection Antibody and continue Add substrate solution and continue Check if the kit is stored at recommended condition and used before expiration date Aliquot reconstituted standard and store at -80. The reconstituted standards should be aliquoted and avoid repeated freeze-thaw cycles. Check / calibrate pipettes Follow the general ELISA protocol Avoid cross contamination by using the sealer appropriately Enriching samples to increase the concentration of antigen Check if the samples are stored at cold environment. Detect samples in timely manner Use multichannel pipettes without touching the reagents on the plate Increase cycles of washes and soaking time between washes Color Reagent should be clear and colorless prior to addition to wells Use clean tubes and pipettes tips Use clean plates, tubes and pipettes tips Non-specificity Samples were contaminated The concentration of samples was too high Avoid cross contamination of samples Try higher dilution rate of samples 18

PRECAUTIONS_ 中文版注意事项 : 1. 本产品仅用于研究, 不能用于临床诊断或治疗 2. 试剂盒必须在保质期内使用 3. 不允许混用来自不同试剂盒和不同批号的试剂 4. 本产品仅能够应用于检测说明书中标注的靶点抗原与样本 其它应用需经使用者设计验证后, 根据结果评估使用的可靠性与准确性 SAFETY INSTRUCTIONS_ 中文版 安全提示 : 1. 本试剂盒中的终止液为酸溶液, 应注意小心操作 2. 所有生物样本均具有潜在生物安全风险, 使用者应严格按照当地法律和相关规定操作处理和丢弃样本 3. 出于安全原因, 操作者应穿戴个人防护装备, 如实验服, 手套, 口罩和护目镜 TECHINICAL TIPS_ 中文版 应用技巧 : 1. 使用前应将试剂盒的所有组分和待检样本温度恢复到室温 2. 冻存样本检测前应彻底化冻并混匀, 并注意避免反复冻融 3. 每次试验均需制备相应的标准曲线, 不同试剂盒以及不同天的标准曲线不能混用 4. 注意在不同样本和步骤间及时更换加样槽和枪头, 避免交叉污染 5. 读取光吸收值应在加入终止液后二十分钟内完成 19

REAGENT PREPARATION_ 中文版 试剂准备 : 使用前应将试剂盒的所有组分和待检样本温度恢复到室温 1 洗涤缓冲液配制 - 如浓缩洗涤缓冲液中已形成结晶, 请平衡到室温至结晶完全溶解, 混匀后取 20 ml 20 浓缩洗涤缓冲液至去离子水或超纯水中, 定容至 400 ml 1 稀释缓冲液的配制 - 如果浓缩稀释缓冲液中已形成结晶, 请平衡到室温至结晶完全溶解, 混匀后取 5 ml 20 浓缩稀释缓冲液至去离子水或超纯水中, 定容至 100 ml 检测抗体的配制 使用前 10,000g 离心 20 秒, 然后用 1 稀释缓冲液将酶标检测抗体稀释至工作浓度,0.5 μ g/ml 底物液的配制 - 使用前 15 分钟将显色 A 液 显色 B 液等体积混合, 避光 确保底物液不被污染, 如混合后的底物液已经变蓝, 请勿使用 标准品复溶 - 将 1mL 1 稀释液加入到冻干标准品的安瓶中制备标准品储液, 充分溶解, 混匀后 ( 勿翻转管子 ) 等体积分装,-80 度保存, 复溶后的储液浓度应根据冻干标准品标签上的标注蛋白量进行计算 标准曲线的制备 - 取 8 个管, 按照标准品浓度依次进行标记, 移取 1000 μ L 1 稀释缓冲液至标记为 1000 pg/ml 的离心管中, 其余各管移取 500 μ L, 根据标准品储液浓度计算 1000 pg/ml 标准品应移取的储液体积, 加至离心管中, 混匀, 取 500 μ L 至下一标记浓度的离心管中, 混匀 进行一系列倍比稀释 ;1000 pg/ml 为标准曲线最高点,1 稀释缓冲液为空白 (0 pg/ml) 每次试验均需制备相应的标准曲线, 不同试剂盒以及不同天的标准曲线不能混用 下图仅用于标准曲线制备范例展示, 由于冻干标准品的批次差异, 复溶后标准品储液的蛋白浓度不同, 应根据实际浓度计算配制标准曲线所需的储液体积 20

ASSAY PROCEDURE_ 中文版试验流程 : 使用前应将试剂盒的所有组分和待检样本温度恢复到室温 强烈建议所有的标准品和待检样本进行双复孔测定 1. 按前述试剂准备项准备好各种试剂 标准品和待测样本 2. 计算检测样本所需酶标条, 将酶标条从铝箔袋取出, 剩余的酶标条放回铝箔袋中并封好袋口, 低温保存 3. 洗板 : 用 1 洗涤缓冲液 (300 μ L/ 孔 ) 洗板三次, 拍干酶标板 洗板对试验结果有重要影响, 确保最后一次拍板没有洗液残留 4. 样本孵育 : 加入标准品和待测样本,100 μ L/ 孔, 确保 15 分钟内完成点样, 室温孵育 2 小时 5. 洗板 : 弃去孔中液体, 加入 1 洗涤缓冲液 (300 μ L/ 孔 ) 洗板三次, 拍干酶标板 6. 酶标检测抗体孵育 : 将预先配制至工作浓度的检测抗体加入酶标板中,100μ L/ 孔, 混匀, 室温孵育 1 小时 7. 洗板 : 弃去孔中液体, 加入 1 洗涤缓冲液 (300 μ L/ 孔 ) 洗板三次, 拍干酶标板 8. 显色 : 将预先配制的底物液加入酶标板中,200 μ L/ 孔, 混匀, 室温避光孵育 20 分钟 9. 终止 : 加入 50 μ L/ 孔终止液至酶标板中, 轻轻震动酶标板至显色均匀 10. 读值 :20 分钟内读取 450nm 的光吸收值 21

CALCULATION OF RESULTS_ 中文版 结果处理 : 如果待测样本 OD 值超出标准曲线最高点 OD 值, 需将样本进行稀释后重新测定 取标准品 空白对照 样本的平均光吸收值, 减去空白对照的平均光吸收值, 得到标准品 样品的光吸收校准值 以标准品浓度为横坐标, 校准后的标准品光吸收值为纵坐标绘制标准曲线 多种绘图和统计学软件可以用于辅助绘制标准曲线并进行未知样本浓度的计算 四参数拟合法往往曲线拟合效果较好, 但其它方法如线性, 双对数法也可能获得较好拟合结果, 需要根据具体实验数据进行分析 22

TYPICAL DATA_ 中文版 示例数据 以下标准曲线图仅供参考, 应以同次实验标准品所绘标准曲线计算标本含量 23

24

ASSAY SUMMARY http://doc.sinobiological.com/reagent/assay_summary.pdf 25

ASSAY SUMMARY_ 中文版 实验流程汇总简图 http://doc.sinobiological.com/reagent/assay_summary_chinese_version.pdf 26

http://www.sinobiological.com Face book Twitter 微信